首页> 外文期刊>Gastroenterology Research >Percutaneous Biliary Stent Placement in Palliation of Malignant Bile Duct Obstruction
【24h】

Percutaneous Biliary Stent Placement in Palliation of Malignant Bile Duct Obstruction

机译:经皮胆道支架置入术治疗恶性胆管梗阻

获取原文
           

摘要

Background: To summarize the experiences with the technique of percutaneous biliary stent placement for treatment of malignant biliary obstruction in patients with different types of biliary obstruction. Methods: Percutaneous biliary stent placement was performed in 126 patients with malignant biliary obstruction. The etiology included 56 cases of cholangiocarcinoma, 28 cases of pancreatic cancer, 12 cases of ampullary carcinoma, 10 cases of primary hepatic carcinoma, 8 cases of gastric cancer metastasis, 6 cases of gallbladder carcinoma, and 6 cases of liver metastasis of colon cancer. The obstructed lesion predominantly involved the common bile duct in 42 patients, common hepatic duct in 39 patients, and hilar bile duct in 45 patients. When the bile duct was punctured successfully under fluoroscopy, the guide wire was explored to across the obstruction segment under the assistant of catheter, then the stent was inserted along the super-slippery guide wire. In patients with hilar hepatic duct lesions involving both left and right hepatic ducts, the both ducts were punctured and bilateral stenting was performed. A 8.5 F internal/external drainage catheter was inserted. The liver function test and ultrasound were performed one week after the procedure to observe the decrease of bilirubin and alleviation of biliary obstruction. Results: A total of 166 stents were implanted in 126 patients. In the 42 patients with common bile duct obstruction, each patient was implanted one stent. In the 39 patients with common hepatic duct obstruction, each patient was impanted one stent. In the 45 patients with hilur bile duct obstruction, 38 patients were placed 2 stents, one patient was placed with 3 stents, and the rest were placed with one stent. The serum total bilirubin decreased from 309.2 + 158.3 ?mol/L before the procedure to148.5 98.0 ?mol/L one week after the procedure (P 0.001). Alkaline phosphatase and alanine aminotransferase significantly decreased (P 0.001). Five cases died within 1 month (4%) after the procedure. Complications occurred in 9 cases (7.1%). Six patients underwent combined duodenal self-expandable metal stent placement successfully?Conclusions: The percutaneous biliary stent placement is a safe and effective palliative therapy for malignant biliary obstruction by improving liver function and 1ife quality.
机译:背景:总结经皮胆道支架置入技术治疗不同类型胆道梗阻患者的恶性胆道梗阻的经验。方法:对126例恶性胆道梗阻患者行经皮胆道支架置入术。病因包括胆管癌56例,胰腺癌28例,壶腹癌12例,原发性肝癌10例,胃癌转移8例,胆囊癌6例,结肠癌肝转移6例。梗阻性病变主要累及胆总管42例,肝总管39例和肝门胆管45例。当在荧光透视下成功穿刺胆管时,探查导线在导管的辅助下穿过阻塞段,然后沿超滑导丝插入支架。对于累及左侧和右侧肝管的肝门肝管病变的患者,将两个管都穿刺并进行双侧支架置入术。插入一个8.5 F内部/外部引流导管。术后1周进行肝功能检查和超声检查,观察胆红素减少及胆道梗阻的缓解情况。结果:126例患者共植入166个支架。在42例胆总管阻塞患者中,每个患者都植入了一个支架。在39例肝总管梗阻患者中,每位患者均植入了一个支架。在45例胆管梗阻患者中,38例患者放置2个支架,1例患者放置3个支架,其余患者放置1个支架。血清总胆红素从手术前的309.2 + 158.3μmol/ L降至手术后1周的148.5 98.0μmol/ L(P <0.001)。碱性磷酸酶和丙氨酸转氨酶显着降低(P <0.001)。术后1个月内有5例死亡(4%)。 9例(7.1%)发生并发症。结论:经皮十二指肠自扩张式金属支架置入术治疗胆道恶性梗阻是一种安全有效的姑息治疗方法,可改善肝脏功能,改善1ife质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号